Literature DB >> 22678368

Anti-IL-17 mAbs herald new options in psoriasis.

Ken Garber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22678368     DOI： 10.1038/nbt0612-475

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Psoriasis: from bed to bench and back.

Authors:  Ken Garber
Journal:  Nat Biotechnol       Date:  2011-07-11       Impact factor: 54.908

2.  Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.

Authors:  Anne Puel; Sophie Cypowyj; Jacinta Bustamante; Jill F Wright; Luyan Liu; Hye Kyung Lim; Mélanie Migaud; Laura Israel; Maya Chrabieh; Magali Audry; Matthew Gumbleton; Antoine Toulon; Christine Bodemer; Jamila El-Baghdadi; Matthew Whitters; Theresa Paradis; Jonathan Brooks; Mary Collins; Neil M Wolfman; Saleh Al-Muhsen; Miguel Galicchio; Laurent Abel; Capucine Picard; Jean-Laurent Casanova
Journal:  Science       Date:  2011-02-24       Impact factor: 47.728

3.  Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis.

Authors:  Kim A Papp; Craig Leonardi; Alan Menter; Jean-Paul Ortonne; James G Krueger; Gregory Kricorian; Girish Aras; Juan Li; Chris B Russell; Elizabeth H Z Thompson; Scott Baumgartner
Journal:  N Engl J Med       Date:  2012-03-29       Impact factor: 91.245
  3 in total
  21 in total

1.  Dermal Vγ4+T cells enhance the IMQ-induced psoriasis-like skin inflammatidon in re-challenged mice.

Authors:  Rong Zhu; Xiaowei Cai; Chunli Zhou; Yashu Li; Xiaorong Zhang; Yiqian Li; Lei Ran; Ke Huang; Weifeng He; Rupeng Wang
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Footrace to clinic heats up for T-cell nuclear receptor inhibitors.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2013-05       Impact factor: 54.908

3.  Retinoic acid-induced autoantigen-specific type 1 regulatory T cells suppress autoimmunity.

Authors:  Mathilde Raverdeau; Maria Christofi; Anna Malara; Mieszko M Wilk; Alicja Misiak; Lucia Kuffova; Tian Yu; Aoife M McGinley; Shauna M Quinn; Chandirasegaran Massilamany; Jay Reddy; John V Forrester; Kingston Hg Mills
Journal:  EMBO Rep       Date:  2019-03-20       Impact factor: 8.807

Review 4.  The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing.

Authors:  Sarah L Gaffen; Renu Jain; Abhishek V Garg; Daniel J Cua
Journal:  Nat Rev Immunol       Date:  2014-09       Impact factor: 53.106

5.  How can we manage resistance to antiangiogenic drugs?

Authors:  Dai Chu Luu; Joseph Chao
Journal:  Clin Investig (Lond)       Date:  2014

6.  Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice.

Authors:  Ia Khmaladze; Tiina Kelkka; Simon Guerard; Kajsa Wing; Angela Pizzolla; Amit Saxena; Katarina Lundqvist; Meirav Holmdahl; Kutty Selva Nandakumar; Rikard Holmdahl
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

7.  Mining the human autoantibody repertoire: isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymoma.

Authors:  Roger R Beerli; Monika Bauer; Andrea Fritzer; Lindsey B Rosen; Regula B Buser; Markus Hanner; Melanie Maudrich; Mario Nebenfuehr; Jorge Alejandro Sepulveda Toepfer; Susanne Mangold; Anton Bauer; Steven M Holland; Sarah K Browne; Andreas Meinke
Journal:  MAbs       Date:  2014       Impact factor: 5.857

Review 8.  The future of uveitis treatment.

Authors:  Phoebe Lin; Eric B Suhler; James T Rosenbaum
Journal:  Ophthalmology       Date:  2013-10-26       Impact factor: 12.079

Review 9.  Immunity to infection in IL-17-deficient mice and humans.

Authors:  Sophie Cypowyj; Capucine Picard; László Maródi; Jean-Laurent Casanova; Anne Puel
Journal:  Eur J Immunol       Date:  2012-09       Impact factor: 5.532

10.  The Dynamic Duo-Inflammatory M1 macrophages and Th17 cells in Rheumatic Diseases.

Authors:  Jun Li; Hui-Chen Hsu; John D Mountz
Journal:  J Orthop Rheumatol       Date:  2013-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.